Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN)

CUSIP: 92790C104

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
95,489,675
Total 13F shares
91,362,677
Share change
+758,044
Total reported value
$1,231,598,393
Put/Call ratio
60%
Price per share
$13.48
Number of holders
174
Value change
-$2,447,073
Number of buys
90
Number of sells
81

Quarterly Holders Quick Answers

What is CUSIP 92790C104?
CUSIP 92790C104 identifies VRDN - Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN) as of Q1 2025

As of 31 Mar 2025, Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN) was held by 174 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 91,362,677 shares. The largest 10 holders included FMR LLC, BlackRock, Inc., Deep Track Capital, LP, Kynam Capital Management, LP, VANGUARD GROUP INC, VR ADVISER, LLC, COMMODORE CAPITAL LP, Fairmount Funds Management LLC, STATE STREET CORP, and TANG CAPITAL MANAGEMENT LLC. This page lists 174 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.